February 8, 2022 12:01 PM ESTUpdated February 11, 10:23 AM
Pharma
Marketing

Mar­ket­ingRx roundup: Ab­b­Vie de­buts Qulip­ta mi­graine TV ads; Lil­ly fo­cus­es on Olympic ath­lete in boy­cotted Games

Beth Snyder Bulik

Senior Editor

Ab­b­Vie launched its first main­stream ad cam­paign for mi­graine pre­ven­tion med Qulip­ta. In two 45-sec­ond TV com­mer­cials, peo­ple are shown staving …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

Trump names Johns Hop­kins re­searcher Mar­ty Makary to lead the FDA; al­so names CDC, Sur­geon Gen­er­al picks

FDA ap­proves Bridge­Bio's heart dis­ease drug, set­ting up com­pe­ti­tion with Pfiz­er, Al­ny­lam

Drug or bi­o­log­ic? An Eli Lil­ly law­suit could im­pact weight loss drug com­pounders

Sur­round­ed by AI bio gi­ants, tiny start­up Nabla Bio makes de no­vo an­ti­bod­ies look more like drugs 

Pa­tient dies in Neu­ro­gene's Rett syn­drome study

sponsored

Are pro­grams with com­pound­ed GLP-1s safe for your pop­u­la­tion?

A service from the Financial Times